Emerging studies get more info suggest this peptide, a dual agonist targeting both the gut-brain axis and GIP , appears to provide a promising step forward for weight treatment. Initial clinical trials have indicated impressive reductions in abdominal tissue, possibly surpassing other obesity therapies . However , further assessment is needed to co